Prestige Consumer Healthcare Inc. P/E Ratio 2010–2026
Prestige Consumer Healthcare Inc. reported 15.16 of price-to-earnings ratio for fiscal 2026. That was 24.4% lower than fiscal 2025. Compared with fiscal 2021, the change was +11.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2026 | 15.16 | -24.4% |
| FY 2025 | 20.04 | +15.2% |
| FY 2024 | 17.40 | — |
| FY 2023 | — | — |
| FY 2022 | 13.10 | -3.4% |
| FY 2021 | 13.56 | +2.8% |
| FY 2020 | 13.19 | — |
| FY 2019 | — | — |
| FY 2018 | 5.32 | -87.6% |
| FY 2017 | 42.74 | +50.5% |
| FY 2016 | 28.40 | -1.3% |
| FY 2015 | 28.79 | +46.8% |
| FY 2014 | 19.60 | -3.1% |
| FY 2013 | 20.23 | -15.5% |
| FY 2012 | 23.95 | +20.8% |
| FY 2011 | 19.83 | +41.0% |
| FY 2010 | 14.06 | — |
Source: Prestige Consumer Healthcare Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PBH 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Prestige Consumer Healthcare Inc. reported 15.16 of price-to-earnings ratio for fiscal 2026. That was 24.4% lower than fiscal 2025. Compared with fiscal 2021, the change was +11.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Prestige Consumer Healthcare Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePrestige Consumer Healthcare Inc. — frequently asked questions
What is Prestige Consumer Healthcare Inc.'s price-to-earnings ratio?
Prestige Consumer Healthcare Inc. (PBH) reported price-to-earnings ratio of 15.16 for fiscal year 2026, per its SEC filings.
How has Prestige Consumer Healthcare Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2010 and 2026, PBH's price-to-earnings ratio grew at roughly 0.5% per year (compound annual rate), from 14.06 to 15.16.
Where does this data come from?
Figures are computed from Prestige Consumer Healthcare Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More PBH financial history
Full PBH fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →